EDGAR Filing Documents for 0001104659-23-039822

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001104659-23-039822

Filing Date

2023-03-31

Accepted

2023-03-31 10:29:24

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	tm2311129d1_424b5.htm	424B5	869228
2	GRAPHIC	tm2311129d1_424b5img001.jpg	GRAPHIC	14791
	Complete submission text file	0001104659-23-039822.txt		890927

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 424B5 | Act: 33 | File No.: 333-251673 | Film No.: 23784103
SIC: 2834 Pharmaceutical Preparations